| 2002~2005年我国抗心律失常药市场状况及趋势分析 |
| |
| 引用本文： | 白玉国,张爱琴,张石革.2002~2005年我国抗心律失常药市场状况及趋势分析[J].中国药房,2007,18(1):19-21. |
| |
| 作者姓名： | 白玉国 张爱琴 张石革 |
| |
| 作者单位： | 1. 北京安贞医院药剂科,北京市,100029
2. 北京积水潭医院药剂科,北京市,100035 |
| |
| 摘 要： | 目的:为临床合理、安全应用抗心律失常药提供参考。方法:收集2002~2005年我国抗心律失常药应用数据,并进行对比分析。结果:抗心律失常药销售金额呈逐年上升趋势,用药频度排序前5位药品各年基本相同,包括普罗帕酮、胺碘酮、美西律、莫雷西嗪和阿普林定。结论:我国抗心律失常药应用较为合理;新的Ⅲ类抗心律失常药的应用有增长趋势。
|
| 关 键 词： | 抗心律失常药 普罗帕酮 销售金额 市场分析 |
| 文章编号： | 1001-0408（2007）01-0019-03 |
| 收稿时间： | 2006-07-18 |
| 修稿时间： | 2006-09-08 |
Chinese Market for Antiarrhythmic Drugs: Status and Trends in 2002～2005 |
| |
| BAI Yuguo,ZHANG Aiqin,ZHANG Shige.Chinese Market for Antiarrhythmic Drugs: Status and Trends in 2002～2005[J].China Pharmacy,2007,18(1):19-21. |
| |
| Authors: | BAI Yuguo ZHANG Aiqin ZHANG Shige |
| |
| Institution: | Dept. of Pharmacy, Beijing Anzhen Hospital, Beijing 100029, China;Dept. of Pharmacy, Jishuitan Hospital in Beijing, Beijing 100035, China |
| |
| Abstract: | OBJECTIVE: To evaluate the current situation and trends of antiarrhythmic drug use in China and provide references for rational, efficient and economical use of antiarrhythmic drugs in clinic. METHODS: The sales volume, sales amount of antiarrhythmic drugs from 2002 to 2005 in China were investigated and analyzed. RESULTS: The drugs that dominated the first 5 places were almost the same in 4 years, i.e. propafenone, amiodarone, mexiletine, moricizine and aprindine. CONCLUSION: The clinical application of antiarrhythmic drugs in China was rational and Class Ⅲ antiarrhythmic drugs will be more and more popular. |
| |
| Keywords: | Antiarrhythmic drug Propafenone Sales amount Marketing analysis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
